Skip to content
Search

Latest Stories

Speculation about Kim Kardashian's weight loss leads to soaring demand for vital diabetes drug

A TikTok-fuelled stampede for the obesity drug has now led to a global shortage.

Speculation about Kim Kardashian's weight loss leads to soaring demand for vital diabetes drug

In February, the National Institute for Health, and Care Excellence (NICE) approved a weekly jab for obese patients with weight-related diseases, such as type 2 diabetes, or for those at high risk of a heart attack, as losing weight can help protect against these health issues.

However, when in May, reality TV star Kim Kardashian revealed that she had lost 16 lbs in three weeks to fit into a dress that once belonged to Marilyn Monroe, rumours began to circulate that she had used the drug semaglutide which is licensed for use only in those who are obese and suffering with health problems, the Daily Mail reports.


Speculation about Kardashian's weight loss led to high demand for the drug and a TikTok-fuelled stampede for the obesity drug has now led to a global shortage, leaving patients with severe health problems such as type 2 diabetes without the crucial treatment.

Though Kardashian has never commented on the claims, in one TikTok clip, viewed more than a million times, an evangelical patient speculates, ‘In my opinion, Kim’s drastic weight loss could be due to something like [semaglutide]… I might be wrong. These [medicines] are tools for people to completely metabolically change their bodies.’

The medication semaglutide, known by brand names Ozempic and Wegovy, is considered to be a major breakthrough, helping those who take it to shed almost a fifth of their weight.

Therefore, the hashtag #ozempic has garnered more than 270 million views on the social media platform, with hundreds of millions of views for #semaglutide, #wegovy, and similar hashtags.

In October, entrepreneur Elon Musk too had claimed on Twitter that he had lost weight due to the drug, semaglutide.

This drug reportedly works by suppressing appetite, and users apparently crave less and sometimes even forget to eat.

The phenomenal success of the drug has led to rising demand in the US, where about 40% of the population, is reportedly obese.

But apparently, semaglutide is also being prescribed to even those people who are not obese.

‘Styling teams for celebrities have come to accept the injections as part of grooming rituals,’ reports the entertainment magazine Variety. ‘It has become the worst-kept secret in Hollywood.’

The soaring demand has led to stocks of the drug running dry, and the drug’s manufacturer Novo Nordisk UK has established that it is ‘aware of a stock shortage.’

It adds, ‘Unprecedented demand has tested our manufacturing capacity. We are working to remedy this as soon as possible.’

Obesity expert Dr Carel le Roux, Professor of Metabolic Medicine at Ulster University is reported to have said, ‘Without semaglutide, patients relapse – they become incredibly hungry and are drawn to consume more food. They regain weight and their health suffers.’

According to experts, the drug works by mimicking the hormone glucagon-like peptide-1 (GLP-1), which is released after eating.

It signals to the body to release another hormone, known as insulin – this helps move digested sugar from the blood into cells where it can be used for energy, leading to a feeling of being full.

Trials of semaglutide last year caused a stir when it was revealed that patients, on average, lost 16% of their body weight after being on the drug for a year.

This result was reportedly seen even if the patients didn’t change their diet.

A private prescription for the drug costs roughly £100 a month, and many medics are of the opinion that obese patients should be offered the treatment on the NHS before the development of serious conditions such as type 2 diabetes.

‘Obesity is a disease that affects part of the brain involved with feelings of hunger,’ explains Prof le Roux, who runs the campaign group It’s Not Your Fault.

He adds, ‘It’s a biological problem that can’t be controlled with willpower.

‘Semaglutide targets the part of the brain affected by the disease of obesity. Ultimately the goal of treatment is to improve health, not what people see in the mirror.’

Although according to NICE semaglutide can be offered for two years only, Prof le Roux expects this to change.

He reportedly said, ‘There isn’t the evidence yet to show having patients on semaglutide for longer is cost-effective in terms of preventing illness.’

‘Next year we’ll have data to show whether or not the treatment reduces the risk of heart attacks. If it does, there will be a strong argument to put patients on it for life.’

Prof le Roux believes there is currently a shortage of semaglutide due to the staggering number of obese Americans who require it.

However, he warns that those who take this drug to get slim could be shocked by the consequences.

He states, ‘There is a rebound effect when the drug is stopped. Natural levels of GLP-1 will be lower, meaning patients will feel hungrier and end up heavier than before.

This drug will not make someone thin – it’s a treatment for obesity.’

More For You

Trump

Trump said the suspect had been arrested earlier for 'terrible crimes,' including child sex abuse, grand theft auto and false imprisonment, but was released under the Biden administration because Cuba refused to take him back.

Getty Images

Trump says accused in Dallas motel beheading will face first-degree murder charge

US PRESIDENT Donald Trump has described Chandra Mouli “Bob” Nagamallaiah, the Indian-origin motel manager killed in Dallas, as a “well-respected person” and said the accused will face a first-degree murder charge.

Nagamallaiah, 50, was killed last week at the Downtown Suites motel by co-worker Yordanis Cobos-Martinez, a 37-year-old undocumented Cuban immigrant with a criminal history.

Keep ReadingShow less
Starmer Mandelson

Starmer talks with Mandelson during a welcome reception at the ambassador's residence on February 26, 2025 in Washington, DC.

Getty

Starmer under pressure from party MPs after Mandelson dismissal

PRIME MINISTER Keir Starmer is facing questions within the Labour party after the sacking of US ambassador Peter Mandelson.

Mandelson was removed last week after Bloomberg published emails showing messages of support he sent following Jeffrey Epstein’s conviction for sex offences. The dismissal comes just ahead of US president Donald Trump’s state visit.

Keep ReadingShow less
Nepal’s new leader pledges to act on Gen Z calls to end corruption

Officials greet newly-elected Prime Minister of Nepal's interim government Sushila Karki (R) as she arrives at the prime minister's office in Kathmandu on September 14, 2025. (Photo by PRABIN RANABHAT/AFP via Getty Images)

Nepal’s new leader pledges to act on Gen Z calls to end corruption

NEPAL’s new interim prime minister Sushila Karki on Sunday (14) pledged to act on protesters’ calls to end corruption and restore trust in government, as the country struggles with the aftermath of its worst political unrest in decades.

“We have to work according to the thinking of the Gen Z generation,” Karki said in her first address to the nation since taking office on Friday (12). “What this group is demanding is the end of corruption, good governance and economic equality. We will not stay here more than six months in any situation. We will complete our responsibilities and hand over to the next parliament and ministers.”

Keep ReadingShow less
UK secures £1.25bn US investment ahead of Trump’s visit

US president Donald Trump and UK prime minister Sir Keir Starmer arrive at Trump International Golf Links on July 28, 2025 in Balmedie, Scotland. (Photo by Jane Barlow-WPA Pool/Getty Images)

UK secures £1.25bn US investment ahead of Trump’s visit

THE British government has announced over £1.25 billion ($1.69bn) in fresh investment from major US financial firms, including PayPal, Bank of America, Citigroup and S&P Global, ahead of a state visit by president Donald Trump.

The investment is expected to create 1,800 jobs across London, Edinburgh, Belfast and Manchester, and deepen transatlantic financial ties, the Department for Business and Trade said.

Keep ReadingShow less
Nearly 150,000 join anti-migrant protest in London as clashes erupt

Protesters wave Union Jack and St George's England flags during the "Unite The Kingdom" rally on Westminster Bridge by the Houses of Parliament on September 13, 2025 in London, England. (Photo by Christopher Furlong/Getty Images)

Nearly 150,000 join anti-migrant protest in London as clashes erupt

MORE THAN 100,000 protesters marched through central London on Saturday (13), carrying flags of England and Britain and scuffling with police in one of the UK's biggest right-wing demonstrations of modern times.

London's Metropolitan Police said the "Unite the Kingdom" march, organised by anti-immigrant activist Tommy Robinson, was attended by nearly 150,000 people, who were kept apart from a "Stand Up to Racism" counter-protest attended by around 5,000.

Keep ReadingShow less